Journal of Virus Eradication, 2017; 3: 168–184 Daily use of co-formulated tenofovir and emtricitabine for HIV pre-exposure prophylaxis (PrEP) by populations at high risk of HIV infection is now recommended in guidelines from the United States, Europe and Australia and globally through the 2015 WHO guidelines. These 2017 Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine‘s...
The Washington Post, Published on July 26, 2017 Nobody can say exactly how many women have had Essure implanted since the device went on the market in 2002. Bayer, which is headquartered in Germany, says that more than 750,000 devices have been sold worldwide and that sales “continue to grow.” In recent years, the [US] Food and Drug Administration has received more than 16,000 adverse-event...
UNAIDS, 19 JULY 2017 Key messages: 1. There is growing scientific consensus that people living with HIV who are taking effective antiretroviral therapy and whose virus is suppressed to undetectable levels will not transmit HIV sexually. 2. Treatment is first and foremost about enabling the person living with HIV to regain and maintain good health. Globally, there needs to be better access to...
SHINE SA, July 2017 Today, July 28th, is World Hepatitis Day. There are no ‘healthy carriers’ of hepatitis B! SA Health & SHINE SA are promoting a 6-minute video providing advice for general practitioners in diagnosing, managing and contact tracing patients with chronic hepatitis B (CHB), to assist in preventing serious liver disease. It is now known that people who were...
The Human Rights Campaign, July 26, 2017 Today, HRC issued the following statement in response to an amicus brief filed by the Department of Justice arguing that Title VII does not protect lesbian, gay, or bisexual people on the basis of sex: “Attacks against the LGBTQ community at all levels of government continue to pour in from the Trump-Pence Administration,” said Sarah Warbelow, HRC Legal...
National Institute of Allergy and Infectious Diseases (NIAID), July 24, 2017 A nine-year-old South African child who was diagnosed with HIV infection at one month of age and received anti-HIV treatment during infancy has suppressed the virus without anti-HIV drugs for eight and a half years, scientists reported today at the 9th IAS Conference on HIV Science in Paris. This case appears to be the...